High materiality9/10
Bernstein reiterates Outperform Rating on Guardant Health (GH)
Why it may matterVerify against the original reporting
Upside potential; bullish setup.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Bernstein reiterates Outperform; target raised to $210; current price is $161.25.
- Bernstein reiterates Outperform on GH
- Target $210; Current price $161.25
Key facts
- 01
Target: $210
- 02
Posted price: $161.25
- 03
Analyst firm: Bernstein
- 04
Analyst: Eve Burstein
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.